Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Slides: 1–12 of 813
Add to tray Remove from tray

Introduction

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: introduction | feasibility | study size | rationale | interpretation
Add to tray Remove from tray

Study Size and Power Calculations in Randomized Controlled Trials (3 of 3)

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: study size | power calculation | statistical significance | type 1 error
Add to tray Remove from tray

Considerations for Observational Comparative Effectiveness Research Study Size Planning

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: observational comparative effectiveness research | study size
Add to tray Remove from tray

Considerations That Differ From Nonrandomized Studies

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: considerations | nonrandomized study | randomized controlled trial
Add to tray Remove from tray

Clostridium difficile Infections: Diagnosis, Treatment, and Prevention

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: Agency for Healthcare Research and Quality | diagnosis | prevention | treatment | Clostridium difficile
Add to tray Remove from tray

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: Agency for Healthcare Research and Quality (AHRQ) | C. difficile Infection (CDI) | systematic review | comparative effectiveness review development
Add to tray Remove from tray

Overview: Objectives

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: diagnostic tests | objectives | prevention | treatment | overview
Add to tray Remove from tray

Overview: Results for Diagnostic Testing

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: overview | diagnostic testing | immunoassays | sensitivity | specificity
Add to tray Remove from tray

Overview: Results for Treatment of CDI with Standard Antibiotics

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibiotics | fidaxomicin | results | treatment | vancomycin | overview
Add to tray Remove from tray

Overview: Results for Nonstandard Interventions to Treat CDI or Reduce the Risk of Recurrence

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibodies | C. difficile immune whey | fecal transplantation | nonstandard interventions | prebiotics | probiotics | recurrence | overview
Add to tray Remove from tray

Overview: Conclusions

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: conclusions | diagnostic assays | patient outcomes | prevention | treatment | overview
Add to tray Remove from tray

Introduction: Incidence of C.difficile Infection (CDI)

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | healthcare-associated infection | morbidity | mortality | incidence
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364